Loading
Latest filing published 25 Aug 2020 for GlobeStar Therapeutics Corp, €423.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alex K. Blankenship appears in our data through filings on GlobeStar Therapeutics Corp shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 11 August 2016 and the latest from 14 August 2020.
No open-market sale appears; the market trades are 7 purchases worth €4.4B. The amount is not disclosed for 4 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2020, the count stands at 5 purchases and no sales.
The median purchase comes to €897.7M.
Most recently, on 25 August 2020, the filings show an open-market purchase worth €3.5B in GlobeStar Therapeutics Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations